-
PharmaCielo Q2 2023 Results: Revenue Drops But CEO Is Optimistic About Future Growth
Tuesday, August 29, 2023 - 4:20pm | 537PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announced its financial results on Tuesday for the second quarter ended June 30...
-
PharmaCielo Ships Dried Cannabis Flower To The Czech Republic, Expanding Its Exports To EU
Thursday, September 15, 2022 - 9:31am | 398PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) has made its first shipment of THC-dominant dried cannabis flower to a customer in the Czech Republic, in the EU market. The customer is an established cannabinoid-focused pharmaceutical distributor and clinical research organization in the country. The...
-
PharmaCielo Signs Sales Agreement With Brazilian Phyto-Therapeutic Company
Thursday, July 28, 2022 - 9:11am | 431PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) , the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., entered into a supply agreement with one of the largest phyto-therapeutic companies in the...
-
PharmaCielo Ships CBD Full Spectrum Oil To A Brazilian Pharmaceutical Company
Monday, June 6, 2022 - 10:11am | 589PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., shipped an initial shipment of a CBD full spectrum extract with THC content to a well-...